A Phase 2 Study of CPI-0610, a Small Molecule Inhibitor of Bromodomain and Extra-Terminal (BET) Proteins, in Patients With Malignant Peripheral Nerve Sheath Tumors
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs CPI 0610 (Primary)
- Indications Nerve sheath neoplasms
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2017 Status changed from not yet recruiting to recruiting.
- 03 Jul 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jul 2017.
- 20 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.